Association of Cytotoxic T Lymphocyte-associated antigen-4 gene haplotype with the susceptibility to gastric cancer

Molecular Biology Reports

Volumn 37, Issue 1, 2010, Pages 515-520

  Hou, Ruiping ^a   Cao, Bangwei ^b   Chan, Zhongdong ^c   Li, Yong ^d   Ning, Tao ^d   Li, Chunhui ^a   Xu, Changqing ^a   Chen, Ziping ^a  

^a SHANDONG UNIVERSITY   (China)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

^c Seventh Hospital of Zhengzhou   (China)

^d PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

CTLA 4; Gastric cancer; Haplotype; Susceptibility

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; STOMACH CANCER;

ANTIGENS, CD; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; STOMACH NEOPLASMS;

EID: 77949263641     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-009-9705-1     Document Type: Article

References (22)

1. WK Leung MS Wu Y Kakugawa JJ Kim KG Yeoh KL Goh KC Wu DC Wu J Sollano U Kachintorn T Gotoda JT Lin WC You EK Ng JJ Sung 2008 Screening for gastric cancer in Asia: current evidence and practice Lancet Oncol 9 279 287 10.1016/S1470-2045(08)70072-X 10.1016/S1470-2045(08)70072-X 18308253 (Pubitemid 351722947)
2. V Catalano R Labianca GD Beretta G Gatta F de Braud E Van Cutsem 2005 Gastric cancer Crit Rev Oncol Hematol 54 209 241 10.1016/j.critrevonc.2005.01. 002 10.1016/j.critrevonc.2005.01.002 15890270 (Pubitemid 40703920)
3. S Tsugane S Sasazuki 2007 Diet and the risk of gastric cancer: review of epidemiological evidence Gastric Cancer 10 75 83 10.1007/s10120-007-0420-0 10.1007/s10120-007-0420-0 17577615 (Pubitemid 46955941)
4. ST Mayne SA Navarro 2002 Diet, obesity and reflux in the etiology of adenocarcinomas of the esophagus and gastric cardia in humans J Nutr 132 3467S 3470S 10.1541-6100/jn.2002-132.3647 1:CAS:528:DC%2BD38XovF2ls7k%3D 12421872
5. M Hatakeyama 2009 Helicobacter pylori and gastric carcinogenesis J Gastroenterol 44 239 248 10.1007/s00535-009-0014-1 10.1007/s00535-009-0014-1 1:CAS:528:DC%2BD1MXkt1yitbs%3D 19271114
6. RJ Fijneman 2005 Genetic predisposition to sporadic cancer: how to handle major effects of minor genes? Cell Oncol 27 281 292 10.8606/j.1570-58702005.27- 281 1:CAS:528:DC%2BD2MXhtlCnsr3N 16373962
7. A Hadinia SV Hossieni N Erfani M Saberi-Firozi MJ Fattahi A Ghaderi 2007 CTLA-4 gene promoter and exon 1 polymorphisms in Iranian patients with gastric and colorectal cancers J Gastroenterol Hepatol 22 2283 2287 10.1111/j.1440-1746. 2007.04862.x 10.1111/j.1440-1746.2007.04862.x 1:CAS:528:DC%2BD1cXhtVKhtL8%3D 18031393 (Pubitemid 350145629)
8. MH Sohn SH Kim TW Song KW Kim ES Kim HS Park KE Kim 2007 Cytotoxic T lymphocyte-associated antigen-4 gene polymorphisms confer susceptibility to atopic asthma in Korean children Pediatr Pulmonol 42 542 547 10.1002/ppul.20622 10.1002/ppul.20622 17469155 (Pubitemid 46870386)
9. YK Wong KW Chang CY Cheng CJ Liu 2006 Association of CTLA-4 gene polymorphism with oral squamous cell carcinoma J Oral Pathol Med 35 51 54 10.1111/j.1600-0714.2005.00377.x 10.1111/j.1600-0714.2005.00377.x 1:CAS:528:DC%2BD28Xit1yrtrw%3D 16393254
10. A Ligers N Teleshova T Masterman WX Huang J Hillert 2001 CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms Genes Immun 2 145 152 10.1038/sj.gene.6363752 10.1038/sj.gene.6363752 1:CAS:528: DC%2BD3MXksVyisbc%3D 11426323 (Pubitemid 33674879)
11. L Bouqbis H Izaabel O Akhayat A Perez-Lezaun F Calafell J Bertranpetit D Comas 2003 Association of the CTLA4 promoter region (-1661G allele) with type 1 diabetes in the South Moroccan population Genes Immun 4 132 137 10.1038/sj.gene.6363933 10.1038/sj.gene.6363933 1:CAS:528:DC%2BD3sXivVyqtbs%3D 12618861 (Pubitemid 38967587)
12. LL Hudson K Rocca YW Song JP Pandey 2002 CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region Hum Genet 111 452 455 10.1007/s00439-002- 0807-2 10.1007/s00439-002-0807-2 1:CAS:528:DC%2BD3sXitFWn 12384790 (Pubitemid 36075075)
13. S Sameni MA Ghayumi G Mortazavi Z Faghih MA Kashef A Ghaderi 2009 Lack of association between interleukin-13 gene polymorphisms (-1055 C/T and +2044 G/A) in Iranian patients with lung cancer Mol Biol Rep 36 1001 1005 10.1007/s11033-008-9273-9 10.1007/s11033-008-9273-9 1:CAS:528: DC%2BD1MXjvFejs7w%3D 18506597
14. K Agarwal AJ Czaja DE Jones PT Donaldson 2000 Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis Hepatology 31 49 53 10.1002/hep.510310110 10.1002/hep.510310110 1:CAS:528:DC%2BD3cXks1KqtQ%3D%3D 10613727
15. L Fernandez-Blanco E Perez-Pampin JJ Gomez-Reino A Gonzalez 2004 A CTLA-4 polymorphism associated with susceptibility to systemic lupus erythematosus Arthritis Rheum 50 328 329 10.1002/art.11444 10.1002/art.11444 1:CAS:528:DC%2BD2cXht1Kqs78%3D 14730632 (Pubitemid 38084319)
16. M Stephens NJ Smith P Donnelly 2001 A new statistical method for haplotype reconstruction from population data Am J Hum Genet 68 978 989 10.1086/319501 10.1086/319501 1:STN:280:DC%2BD3M3kslWgsA%3D%3D 11254454 (Pubitemid 32289743)
17. P Mohamadynejad M Saadat 2007 Genetic polymorphisms of XRCC1 (at codons 194 and 399) in Shiraz population (Fars province, southern Iran) Mol Biol Rep 35 669 672 10.1007/s11033-007-9138-7 10.1007/s11033-007-9138-7 17874204
18. N Erfani M Razmkhah AR Talei AM Pezeshki M Doroudchi A Monabati A Ghaderi 2006 Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer Cancer Genet Cytogenet 165 114 120 10.1016/j.cancergencyto.2005.07.020 10.1016/j.cancergencyto.2005.07.020 1:CAS:528:DC%2BD28Xit1aqsL8%3D 16527605 (Pubitemid 43343504)
19. S Movva C Verschraegen 2009 The monoclonal antibody to cytotoxic T lymphocyte antigen 4, ipilimumab (MDX-010), a novel treatment strategy in cancer management Expert Opin Biol Ther 9 231 241 10.1517/14712590802643347 10.1517/14712590802643347 1:CAS:528:DC%2BD1MXlvFemtA%3D%3D 19236253
20. RP Sutmuller LM van Duivenvoorde A van Elsas TN Schumacher ME Wildenberg JP Allison RE Toes R Offringa CJ Melief 2001 Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses J Exp Med 194 823 832 10.1540-9538/2001.194-823 10.1084/jem.194.6.823 1:CAS:528:DC%2BD3MXmvFGgs7w%3D 11560997
21. H Schneider J Downey A Smith BH Zinselmeyer C Rush JM Brewer B Wei N Hogg P Garside CE Rudd 2006 Reversal of the TCR stop signal by CTLA-4 Science 313 1972 1975 10.1126/science.1131078 10.1126/science.1131078 1:CAS:528: DC%2BD28XhtVSnsrnF 16931720 (Pubitemid 44498006)
22. T Kouki Y Sawai CA Gardine ME Fisfalen ML Alegre LJ DeGroot 2000 CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease J Immunol 165 6606 6611 10.1550-6606/j.2000.165-6606 1:CAS:528:DC%2BD3cXosFOhtr4%3D 11086105